SCHEMBL6694034

SCHEMBL6694034

Clc1cc(-c2cc3ccccc3s2)nc2cnccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.41
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
KDM1A O60341 1/20 0.38
LATS1 O95835 2/20 0.38
IKBKB O14920 3/20 0.37
CHUK O15111 1/20 0.37
IKBKG Q9Y6K9 1/20 0.37
CYP3A4 P08684 1/20 0.36
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
PRKCQ Q04759 1/20 0.36
KCNH2 Q12809 1/20 0.36
APP P05067 2/20 0.36
NQO1 P15559 1/20 0.35
NQO2 P16083 1/20 0.35
NR1D1 P20393 1/20 0.35
NR1H3 Q13133 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6534342 0.85 MEN1 (0.45) CYP19A1CYP11B1CYP11B2KDM1AIKBKB
SCHEMBL13220280 0.75 CYP19A1 (0.48) CYP19A1CYP11B1CYP11B2KDM1AIKBKB
SCHEMBL786755 0.75 LATS1 (0.51) LATS1CDK2NPC1RAB9A
SCHEMBL20574275 0.72 LATS1 (0.56) LATS1
SCHEMBL1102744 0.72 NQO1 (0.50) CYP19A1CYP11B1CYP11B2KDM1AIKBKB
SCHEMBL14450973 0.71 CYP19A1 (0.52) CYP19A1CYP11B1CYP11B2KDM1AIKBKB
SCHEMBL3134206 0.70 CYP19A1 (0.50) CYP19A1CYP11B1CYP11B2KDM1AIKBKB
SCHEMBL3138278 0.70 CYP19A1 (0.44) CYP19A1CYP11B1CYP11B2KDM1AIKBKB
SCHEMBL246231 0.69 LATS1 (0.43) LATS1CHUK
SCHEMBL20574285 0.69 LATS1 (0.59) LATS1CYP3A4GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465900-A1 RHO-KINASE INHIBITORS Bayer HealthCare AG (DE) 2004-10-13 EP disclosed
WO-2003059913-A1 ROH-KINASE INHIBITORS BAYER HEALTHCARE AG (DE) 2003-07-24 WO disclosed